Relevant conflicts of interest/financial disclosures: Uriel Heresco-Levy and Daniel C. Javitt have patents for inventions related to the use of glutamatergic amino acids for the treatment of movement disorders.
Glycine site agonists of the N-methyl-d-aspartate receptor and Parkinson's disease: A hypothesis
Article first published online: 20 FEB 2013
Copyright © 2013 Movement Disorders Society
Volume 28, Issue 4, pages 419–424, April 2013
How to Cite
Heresco-Levy, U., Shoham, S. and Javitt, D. C. (2013), Glycine site agonists of the N-methyl-d-aspartate receptor and Parkinson's disease: A hypothesis. Mov. Disord., 28: 419–424. doi: 10.1002/mds.25306
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 8 APR 2013
- Article first published online: 20 FEB 2013
- Manuscript Accepted: 5 NOV 2012
- Manuscript Revised: 26 OCT 2012
- Manuscript Received: 10 MAY 2012
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.